Catalyst Wire Dossier Catalyst Wire Dossier

CISATRACURIUM BESYLATE

CISATRACURIUM BESYLATE · Slate Run Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

37 regulatory and trial events tracked for CISATRACURIUM BESYLATE, covering 2012-02-03 to 2025-06-18. Get the full timeline:

Most recent: FDA Approved: CISATRACURIUM BESYLATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

See pricing